Company / Profit Margin
Jazz Pharmaceuticals Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-8.3%
FY2025
5-year range
-8.3% / 24.2%
FY2021-FY2025
Trend
-160.6%
vs FY2024
Sector context
#71 of 145
Health Care
What the data says
At -8.3%, Jazz Pharmaceuticals's profit margin ranks #71 of 145 in the Health Care sector. Profit Margin has fluctuated over the past 10 years, ranging from -8.3% in FY2025 to 129.7% in FY2017.
Based on SEC 10-K filings.
-8.3% in FY2025 with a 5-year CAGR of -32.0%.
Declined from 10.8% to -8.3% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -18.4pp
- 5-Year Change
- -32.0pp
- 10-Year Change
- -
Sector benchmark
#71 of 145 in Health CareTop 49% of 145This company -8.3% Sector average -792.7%
▼
+98.9% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 160.6% year-over-year.
- Currently 784.3pp above the Health Care sector average.
- Peak profit margin was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8.3% | -160.6% |
| FY2024 | 13.8% | +27.3% |
| FY2023 | 10.8% | +7.1% |
| FY2022 | 10.1% | -58.3% |
| FY2021 | 24.2% | +2.4% |
| FY2020 | 23.6% | -21.6% |
| FY2019 | 30.1% | +13.0% |
| FY2018 | 26.7% | -79.4% |
| FY2017 | 129.7% | +2505.0% |
| FY2016 | 5.0% | -80.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026